Thunder God Vine Dosage and main indications
The medicinal Thunder God Vine dosage on the notice indicates 1 to 1,5mg/kg/day but to take in 3 times after a meal. For example 9 tablets can split in 3 in the morning, 3 at lunch and 3 in the evening. Or 8 tablets can split in 3 + 3 + 2.
I have found in different places that the maximum dose is of 90mg/day, although it is not on this notice. This is also whet my Chinese physician says, although my prescription is currently 100mg/day so this is not written in stone.
Physicians apparently advise to start on the lower dosing basis of 1mg/kg/day in order to evaluate if the extract is well tolerated.
To clarify the dosage information from the notice, the table below shows the number of 10mg tablets of medicinal Thunder God Vine per day according to body weight.
Please also consider reading the medicinal Thunder God Vine safety notice here.
Common Thunder God Vine indications
In China, physician commonly prescribe medicinal Thunder God Vine for (but not limited to) the following autoimmune conditions:
- rheumatoid arthritis,
- systemic lupus erythematosus,
- psoriatic arthritis
- Crohn’s disease,
- ankylosing spondylitis,
- Idiopathic lgA nephropathy…
Clinical studies in their background part, state that medicinal Thunder God Vine extract is a first line treatment for a large range of autoimmune disorders in China. These are the most frequently cited.
If you would like to learn more on the subject, I can suggest to you to type in the Pubmed which is a search engine for medical publications the following : “Tripterygium wilfordii”, which is the scientific name of Thunder God Vine which yields 1243 results of all sorts. If you take the time to read those that are clinical studies, you will find often cited in the background paragraph at the beginning of the study, the common indications of Medicinal Thunder God vine in China.
Also, there are other indications to medicinal Thunder God Vine than autoimmune conditions. These other types of indications I will not discuss here.
|Share or Print this page|